Prefilled Syringes Market is Analytically Rising at a Healthy CAGR of 10.20% During Forecast to 2024
Market
Overview:
A
new report on the global Prefilled
Syringes Market Trends published
by Market Research Future (MRFR), points out that this market could see a rise
at 10.20% CAGR between 2016 and 2024. In terms of money
value, the market can be worth USD 8397.23 Mn by the end of the forecast
period.
Key Players:
·
Baxter
International
·
Becton
Dickinson & Company
·
Gerresheimer
AG
·
Medtronic
·
Nipro
Corporation
·
OMPI
·
Schott
AG
·
Terumo
Corporation
·
Vetter
Pharma International GmbH
·
Weigao
Group
·
West
Pharmaceutical
Market Segmentation:
·
The
global prefilled syringes market segmentation encompasses design, end-user,
material, and type. MRFR’s take on the market surveys various facets of the
market in-depth.
·
The
design-based segmentation of this market covers single-chamber prefilled
syringes, dual-chamber prefilled syringes, and customized prefilled syringes. During
the forecast period, the dual-chamber prefilled syringes segment is expected to
grow at 10.31% CAGR. Single-chamber prefilled syringes segment is expected to
hold the larger market share of 56% in the global market.
·
Regarding
end-users, the market has been segmented into the ambulatory surgical center
and hospitals/clinics. Due to the growing number of public hospitals as well as
private hospitals, the hospitals segment has been anticipated to grow faster
during the forecast period.
·
Based
on material, the market has been segmented into glass prefilled syringes and
plastic syringes. The glass prefilled syringes segment has been sub-segmented
into baked on silicone syringes and oil siliconized syringes. Plastic syringes
segment has higher growth due to its usage in many applications of
pharmaceutical packaging during the forecast period.
·
By
type, the market has been segmented into conventional prefilled syringes and
safety prefilled syringes. Conventional prefilled syringes held the larger
market share of about 68% in 2017.
Regional Segmentation:
The regional analysis of the prefilled
syringes market globally consists of regions is divided into Europe, Americas,
Asia Pacific, Middle East and Africa.
The European region is responsible for
the leading market share of about 41.4 percent in the year 2017 and is expected
to lead the prefilled syringes market globally. The higher share is majorly
attributed to the rising geriatric population, demand for quality healthcare
and growing trend of home-based treatment separate with high healthcare
expenditure.
The Americas region is responsible for
the second biggest market portion, whereas the Asia Pacific region is
anticipated to develop at a rapid expansion rate of about 10.78 percent during
the forecast period. With loads of prospects and unceasingly developing
economies, the region is expected to be among the rapidly growing area.
Moreover, factors such as Japan’s quick adoption of plastic devices along with
the modern healthcare developments, and increasing number of private and public
hospitals, are promoting the growth of the market.
The Middle East and Africa region with
a lesser degree of economic developments and very low-income per capita is
responsible for the minimum market share in 2017 but is likely to develop in
the future.
Latest Industry News
·
Made
by Regeneron, chemistry, manufacturing, and controls prior-approval supplement
for the Eylea injection prefilled syringe that has been approved by the USFDA.
13 AUG 2019
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Comments
Post a Comment